Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Dissolving magnesium membrane could simplify dental implants

NCT ID NCT07646795

Disease control Sponsor: Martina Stefanini Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

When a tooth is removed, the bone and gum often shrink, making it harder to place a dental implant later. This study tests a new magnesium membrane that is placed over a bone graft in the socket. Unlike standard membranes, it is rigid enough to protect the graft but dissolves on its own within about 16 weeks, so no second surgery is needed. Ten adults will be followed for up to 19 months to see how much bone is preserved and whether this approach reduces the need for extra grafting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
magnesium membrane (NOVAMag®) and bovine bone substitute
What this could lead to
If it works, this could offer a simpler, less invasive way to preserve bone after tooth removal, making future dental implant placement easier and reducing the need for additional bone grafting.
What could go wrong
This is a very small, early study with only 10 participants, so results may not apply to everyone. The membrane is new and its benefits over existing options are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

Nov 2024

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Patients agreeing to participate in the study * Age 18 years or older * Periodontally healthy (including patients currently in supportive periodontal maintenance therapy) or patients with ongoing periodontal treatment * Compromised tooth because of severe periodontitis or root fracture * full mouth plaque score \< 20% and full-mouth bleeding score \< 20% at the time of alveolar bone reconstruction Exclusion Criteria: * • Heavy smokers (≥10 cigarettes/day) * Patients with a history of malignancy, radiotherapy, or chemo-therapy for malignancy. * Pregnant patients or nursing during the past 6 months. * Patients taking medications or having treatments with an effect on mucosal healing in general (e.g.steroids, large doses of anti- inflammatory drugs) * Uncontrolled medical conditions, presence of systemic diseases or consumption of medications known to alter bone metabolism * allergic reactions to bovine bone substitute * patients that do not comply with the oral hygiene maintenance program and follow-up visits

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alveolar ridge augmentation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bone fracture Pain periodontitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alveolar ridge augmentation Bone augmentation

Contacts and locations

Locations

  • Periodontal Unit, Department of Biomedical and Neuromotor Sciences, UNiversity of Bologna

    Bologna, BO, 40125, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.